PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11792627-5	2002	The IL-13-enhanced response to UTP/ionomycin was sensitive to bumetanide and DIDS and was reduced in a low-chloride, bicarbonate-free solution.	Ionomycin	35-44	interleukin 13	Homo sapiens	4-9	
17762175-10	2007	IL-13 treatment increased the-resting K(+) permeability as well as the Ca(2+)-dependent K(+) permeability stimulated by UDP or ionomycin.	Ionomycin	127-136	interleukin 13	Homo sapiens	0-5	
12595965-3	2003	The peak increases in ISC (anion secretion) in response to UTP and ionomycin were increased by >8 fold and >13 fold respectively following IL-13 treatment.	Ionomycin	67-76	interleukin 13	Homo sapiens	145-150	
11961080-5	2002	The IC(50) for IL-5 and IL-13 in TPA/ionomycin-stimulated peripheral blood mononuclear cells (PBMC) is 0.7 +/- 0.1 and 0.5 +/- 0.1 microM, respectively, whereas the IC(50) for IFN-gamma is 2.0 +/- 0.4 microM.	Ionomycin	37-46	interleukin 13	Homo sapiens	24-29	
11959794-7	2002	Cyclosporine (CsA) and FK-506 inhibited IL-13 synthesis, when cells were stimulated by TPA/ionomycin.	Ionomycin	91-100	interleukin 13	Homo sapiens	40-45	
11959794-12	2002	Dexamethasone inhibited IL-13 equally effective after alpha-CD3/alpha-CD28 and TPA/ionomycin stimulation.	Ionomycin	83-92	interleukin 13	Homo sapiens	24-29	
11959794-15	2002	MEK inhibitor U0126 inhibited TPA/ionomycin induced IL-13 synthesis very effectively, whereas alpha-CD3/alpha-CD28 stimulated IL-13 induction was resistant to this drug.	Ionomycin	34-43	interleukin 13	Homo sapiens	52-57	
11678905-4	2001	Following re-stimulation in vitro with PMA and ionomycin, CD4+ T cells produced IFNgamma, TNFalpha, TNFbeta, IL-2, IL-4, IL-10 and IL-13.	Ionomycin	47-56	interleukin 13	Homo sapiens	131-136	
9856820-5	1998	Increased production of IL-4 and IL-13 in both CD4+ CD45RO+ T cells and CD8+ CD45RO+ T cells after 4 h in vitro stimulation with phorbol 12-myristate 13-acetate and ionomycin, was more prominent in AD-H patients than in AD-L patients or healthy controls, whereas IFN-gamma-producing CD4+ CD45RO+ T cells and CD8+ CD45RO+ T cells were relatively diminished in AD-H patients.	Ionomycin	165-174	interleukin 13	Homo sapiens	33-38	
10518826-6	1999	After ionomycin activation, 60% to 90% of basophils from both control and allergic asthmatic subjects expressed IL-4 and IL-13.	Ionomycin	6-15	interleukin 13	Homo sapiens	121-126	
10951958-7	2000	After ionomycin activation, a large majority of basophils from both control and allergic asthmatic subjects express IL-4 and IL-13.	Ionomycin	6-15	interleukin 13	Homo sapiens	125-130	
10073603-7	1999	This was also associated with increased cytoplasmic IL-13 expression in phorbol myristate acetate/ionomycin-activated CD3+ cells (6.66+/-3.39%) from patients with nephrotic relapse compared to remission (2.59+/-1.35%) (P < 0.0001).	Ionomycin	98-107	interleukin 13	Homo sapiens	52-57	
9886369-3	1999	Six of 12 human NK clones tested produced IL-13 protein in response to IL-2 or phorbol myristate acetate and ionomycin.	Ionomycin	109-118	interleukin 13	Homo sapiens	42-47	
7629513-2	1995	Ionomycin, but not IgE immune complexes, causes these cells to release serotonin and to express IL-3 and IL-13 mRNA, consistent with their being FC epsilon RI-deficient mast cells.	Ionomycin	0-9	interleukin 13	Homo sapiens	105-110	
30226556-9	2018	The in vitro experiments demonstrated that NGE reduced the phorbol 12-myristate 13-acetate + ionomycin-induced expression of pro-inflammatory cytokines interleukin (IL)-4, IL-13, tumor necrosis factor-alpha, and IL-6 in HMC-1 cells.	Ionomycin	93-102	interleukin 13	Homo sapiens	172-206	
27119568-3	2016	In this study, we demonstrated that exposure of anti-CD3/CD28 or phorbol 12-myristate 13-acetate (PMA)/ionomycin-activated HuT-78 T lymphocyte cells to 10-20 mM d-lactate significantly increased IL-4 and IL-13 production.	Ionomycin	103-112	interleukin 13	Homo sapiens	204-209	
9679857-7	1998	RESULTS: The gene expression of IL-13 by HMC-1 cells and human lung mast cells, which was detected at a low level in an unstimulated condition, was increased by PMA/ionomycin and suppressed by dexamethasone.	Ionomycin	165-174	interleukin 13	Homo sapiens	32-37	
9469423-6	1998	Furthermore, both DC subpopulations expressed IL-13 mRNA and protein following activation with PMA-ionomycin, but not with CD40 ligand, in contrast to IL-12 and IL-10, revealing the existence of different pathways for DC activation.	Ionomycin	99-108	interleukin 13	Homo sapiens	46-51	
9158101-4	1997	Upon stimulation of KU812 cells with either phorbol myristate acetate (PMA) or ionomycin (Iono), IL-4, but not IL-13, was produced in response to Iono, while IL-13, but not IL-4, was inducible by PMA.	Ionomycin	79-88	interleukin 13	Homo sapiens	158-163